These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
194 related articles for article (PubMed ID: 22234275)
1. Hypogonadism in chronic obstructive pulmonary disease: incidence and effects. Balasubramanian V; Naing S Curr Opin Pulm Med; 2012 Mar; 18(2):112-7. PubMed ID: 22234275 [TBL] [Abstract][Full Text] [Related]
2. Hypogonadism, quadriceps weakness, and exercise intolerance in chronic obstructive pulmonary disease. Van Vliet M; Spruit MA; Verleden G; Kasran A; Van Herck E; Pitta F; Bouillon R; Decramer M Am J Respir Crit Care Med; 2005 Nov; 172(9):1105-11. PubMed ID: 16100014 [TBL] [Abstract][Full Text] [Related]
3. Should androgenic anabolic steroids be considered in the treatment regime of selected chronic obstructive pulmonary disease patients? Velema MS; Kwa BH; de Ronde W Curr Opin Pulm Med; 2012 Mar; 18(2):118-24. PubMed ID: 22189453 [TBL] [Abstract][Full Text] [Related]
12. Testosterone metabolism and replacement therapy in patients with end-stage renal disease. Johansen KL Semin Dial; 2004; 17(3):202-8. PubMed ID: 15144546 [TBL] [Abstract][Full Text] [Related]
13. [Optimization of the treatment of chronic obstructive pulmonary disease in men with androgen deficiency]. Vertkin AL; Shakhmanaev AA Klin Med (Mosk); 2014; 92(11):38-42. PubMed ID: 25796945 [TBL] [Abstract][Full Text] [Related]
14. Late-onset male hypogonadism and testosterone replacement therapy in primary care. Brunton SA; Sadovsky R J Fam Pract; 2010 Jul; 59(7 Suppl):S1-8. PubMed ID: 20625573 [TBL] [Abstract][Full Text] [Related]
15. Age-related androgen deficiency and type 2 diabetes. Ryan GJ; Jobe LJ J Pharm Pract; 2011 Jun; 24(3):316-22. PubMed ID: 21676855 [TBL] [Abstract][Full Text] [Related]
16. Testosterone replacement for hypogonadism: clinical findings and best practices. Hengge UR AIDS Read; 2003 Dec; 13(12 Suppl):S15-21. PubMed ID: 14959695 [TBL] [Abstract][Full Text] [Related]
17. [Chronic obstructive pulmonary disease: risk and benefit of testosterone therapy]. Samaras N; Samaras D; Lang PO; Bridevaux PO; Gex G; Janssens JP; Pichard C Rev Med Suisse; 2012 Nov; 8(363):2224-7. PubMed ID: 23240298 [TBL] [Abstract][Full Text] [Related]
18. Testosterone and depression in men. Amiaz R; Seidman SN Curr Opin Endocrinol Diabetes Obes; 2008 Jun; 15(3):278-83. PubMed ID: 18438177 [TBL] [Abstract][Full Text] [Related]
19. The role of accurate testosterone testing in the treatment and management of male hypogonadism. Dobs AS Steroids; 2008 Dec; 73(13):1305-10. PubMed ID: 18639568 [TBL] [Abstract][Full Text] [Related]
20. Testosterone replacement therapy in hypogonadal men: assessing benefits, risks, and best practices. Miner M; Canty DJ; Shabsigh R Postgrad Med; 2008 Sep; 120(3):130-53. PubMed ID: 18824832 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]